Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION).
CONCLUSION: In this pilot randomized trial, IoCRRT was feasible and safe with no difference in complications. Crossover rates were high. Despite high preoperative severity of illness, one-year survival was excellent. These data can inform the design of a larger multicentre trial.
TRIAL REGISTRATION: www.clinicalTrials.gov (NCT01575015); registered 12 April, 2012.
PMID: 31350701 [PubMed - as supplied by publisher]
Source: Canadian Journal of Anaesthesia - Category: Anesthesiology Authors: Karvellas CJ, Taylor S, Bigam D, Kneteman NM, Shapiro AMJ, Romanovsky A, Gibney RTN, Townsend DR, Meeberg G, Özelsel T, Bishop E, Bagshaw SM Tags: Can J Anaesth Source Type: research
More News: Anesthesia | Anesthesiology | Canada Health | Cirrhosis | Dialysis | Intensive Care | Kidney Transplant | Kidney Transplantation | Liver | Liver Disease | Liver Transplant | Transplants | Urology & Nephrology